Biopsy Market: Insights on Scope and Growing Demands in 2030

Comments · 95 Views

Biopsies have advanced significantly in molecular medicine, especially in the field of cancer. Advances in technology have led to improvements in the molecular characterisation of cancers through biopsies. They have been frequently used to determine the stage of the disease, the morphology

Projection of Revenue Growth:

The Biopsy Market size is expected to grow from US$ 32.38 Bn in 2023 to US$ 67.83 Bn by 2030. The Global Biopsy Market is expected to grow at a CAGR of 11.14% through the forecast period (2024 to 2030).

Biopsy Market Overview:

The comprehensive market analysis delves into the dynamic competitive landscape, offering crucial insights into market share data and detailed profiles of top global companies. By thoroughly examining the Biopsy Market, the study identifies the key factors driving regional variations in the industry's growth.

Details insights on this market, request for methodology here:https://www.maximizemarketresearch.com/request-sample/116684/ 

Biopsy Market Scope: 

Following the market valuation phase, comprehensive primary research was undertaken to gather, analyze, and verify essential data. This involved evaluating market size, projecting future trends, identifying key factors, and ensuring data accuracy through triangulation. By employing both top-down and bottom-up approaches, along with additional verification methods, we meticulously examined the market segments and sub-segments. All collected data underwent rigorous qualitative and quantitative analysis to ensure the report provides thorough insights.

Biopsy Market Regional Insights

The detailed regional analysis in Biopsy market research pinpoints key drivers and highlights regulatory changes shaping current and future market trends. By examining both existing and emerging patterns, the research uncovers hidden market potential and identifies profitable opportunities to enhance market positioning. This evaluation, considering both present conditions and future developments, provides a solid foundation for understanding the dynamics of various geographic markets.

Biopsy Market Segmentation

by Product

Instruments
Kits and Consumables
Services


by Type

Tissue Biopsies
Liquid Biopsies
Others


by Application

Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Liver Cancers
Pancreatic Cancers
Ovarian Cancers
Others

Biopsy Market Key Players

North America
1. Illumina, Inc.(U.S)
2. Quest Diagnostics (U.S)
3. Abbott Laboratories (U.S)
4. GenMark Diagnostics(U.S)
5. Bio-Rad Laboratories (U.S)
6. Agilent Technologies (U.S)
7. Biomarker Technologies (U.S)
8. Coherent, Inc. (U.S)
9. Cardinal Health (U.S)
10. BD (Becton, Dickinson and Company) (U.S)
11. Myriad Genetics (U.S)
12. Hologic, Inc. (U.S)
13. Biocept, Inc. (U.S)
14. Thermo Fisher Scientific, Inc. (U.S)
15. Danaher (U.S)
16. Guardant Health (U.S)
17. Exact Sciences Corporation (U.S)
18. Freenome Holdings, Inc. (U.S)
19. Biodesix (Integrated Diagnostics) (U.S)
20. HelioHealth (Laboratory for Advanced Medicine) (U.S)
21. Genesystems, Inc. (Genesys Biolabs)(U.S)
22. GRAIL, Inc. (U.S)
Europe
1. ANGLE Plc (U.K)
2. Oncimmune (U.K)
3. Epigenomics AG (Germany)
4. Qiagen N.V. (Netherlands)
5. F. Hoffmann-La Roche Ltd. (Switzerland)
Asia Pacific
1. Sysmex Corporation (Japan)
2. Olympus(Japan)
3. Lucence Diagnostics Pte. Ltd. (Singapore) 

Please Contact Us On link:https://www.maximizemarketresearch.com/market-report/global-biopsy-market/116684/ 

Conclusion :

The global biopsy market is poised for significant growth, projected to expand from USD 32.38 billion in 2023 to USD 67.83 billion by 2030, driven by technological advancements and increasing demand for less invasive diagnostic methods. The market is characterized by the rising adoption of liquid biopsies, integration of artificial intelligence in pathology, and a growing emphasis on patient comfort and early cancer detection. While high costs and healthcare disparities pose challenges, North America remains the leading region, with substantial contributions from the U.S., while Asia Pacific is expected to experience rapid growth due to increased cancer prevalence and improved healthcare awareness. Continued innovations and improvements in biopsy technologies are likely to shape the future trajectory of the market.

Explore our top-performing reports on the latest trends:

Global Hypochlorous Acid Market https://www.maximizemarketresearch.com/market-report/global-hypochlorous-acid-market/35187/ 
Global Portable Printer Market https://www.maximizemarketresearch.com/market-report/global-portable-printer-market/28944/ 

About Maximize Market Research: 

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT telecom, chemical, food beverage, aerospace defense, healthcare and others.

Contact Maximize Market Research: 

MAXIMIZE MARKET RESEARCH PVT. LTD.

   ⮝ 3rd Floor, Navale IT park Phase 2,

   Pune Banglore Highway, Narhe

   Pune, Maharashtra 411041, India.

   ✆ +91 9607365656

  ? sales@maximizemarketresearch.com

? www.maximizemarketresearch.com